|
|
|
|
||
OT: co3aiiXeres . In addition, it develops ready-to-use diazepam formulation, which is in Phase Ib clinical trial for the treatment of Dravet syndrome and acute repetitive seizures in patients with epilepsy; and Pramlintide-Insulin co-formulation that is Phase II clinical trials for treating type 1 and 2 diabetes. Xeris Pharmaceuticals, Inc. serves patients, caregivers, and health practitioners. The company was founded in 2005 and is headquartered in Chicago, Illinois. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
1654 | Re: OT: co3aii | co3aii | 1 | 8/13/2020 3:14:26 PM |